Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study

被引:13
作者
Ebrahimi, Fahim [1 ,2 ,11 ]
Simon, Tracey G. [1 ,3 ,4 ,5 ]
Hagstrom, Hannes [6 ,7 ]
Soderling, Jonas [1 ,8 ]
Wester, Axel [7 ]
Roelstraete, Bjorn [1 ]
Ludvigsson, Jonas F. [1 ,9 ,10 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Univ Ctr Gastrointestinal & Liver Dis, Dept Gastroenterol & Hepatol, Basel, Switzerland
[3] Massachusetts Gen Hosp, Div Gastroenterol & Hepatol, Boston, MA 02114 USA
[4] Harvard Med Sch, Boston, MA USA
[5] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit CTEU, Boston, MA USA
[6] Karolinska Univ Hosp, Dept Upper GI, Div Hepatol, Stockholm, Sweden
[7] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[8] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden
[9] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden
[10] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA
[11] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden
基金
瑞士国家科学基金会;
关键词
Hospitalization; Immune System; Infection; Metabolic Syndrome; Nonalcoholic Fatty Liver Disease; FIBROSIS STAGE; BACTERIAL-INFECTIONS; EPIDEMIOLOGY; ASSOCIATION; MECHANISMS; MORTALITY; CIRRHOSIS; OUTCOMES; NASH;
D O I
10.1016/j.cgh.2023.05.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: It has been suggested that patients with nonalcoholic fatty liver disease (NAFLD) might be at increased risk of severe infections, but large-scale data from cohorts with biopsy-proven NAFLD are lacking.METHODS: Population-based cohort study including all Swedish adults with histologically confirmed NAFLD (n = 12,133) from 1969 to 2017. NAFLD was defined as simple steatosis (n = 8232), nonfibrotic steatohepatitis (n = 1378), noncirrhotic fibrosis (n = 1845), and cirrhosis (n = 678). Patients were matched to 5 pound population comparators (n = 57,516) by age, sex, calendar year, and county. Swedish national registers were used to ascertain incident severe infections requiring hospital admission. Multivariable adjusted Cox regression was used to estimate hazard ratios in NAFLD and histopathological subgroups.RESULTS: Over a median of 14.1 years, 4517 (37.2%) patients with NAFLD vs 15,075 (26.2%) comparators were hospitalized for severe infections. Patients with NAFLD had higher incidence of severe infections than comparators (32.3 vs. 17.0/1000 person-years; adjusted hazard ratio [aHR], 1.71; 95% confidence interval, 1.63L1.79). The most frequent infections were respiratory (13.8/1000 person-years) and urinary tract infections (11.4/1000 person-years). The absolute risk difference at 20 years after NAFLD diagnosis was 17.3%, equal to one extra severe infection in every 6 patients with NAFLD. Risk of infection increased with worsening histological severity of NAFLD (simple steatosis [aHR, 1.64], nonfibrotic steatohepatitis [aHR, 1.84], noncirrhotic fibrosis [aHR, 1.77], and cirrhosis [aHR, 2.32]. Also compared with their full siblings, patients with NAFLD were at increased risk of severe infections (aHR, 1.54; 95% confidence interval, 1.40-1.70).CONCLUSIONS: Patients with biopsy-proven NAFLD were at significantly higher risk of incident severe infection requiring hospitalization both compared with the general population and compared with siblings. Excess risk was evident across all stages of NAFLD and increased with worsening disease severity.
引用
收藏
页码:3346 / 3355.e19
页数:29
相关论文
共 46 条
  • [1] Diabetes and the occurrence of infection in primary care: a matched cohort study
    Abu-Ashour, Waseem
    Twells, Laurie K.
    Valcour, James E.
    Gamble, John-Michael
    [J]. BMC INFECTIOUS DISEASES, 2018, 18
  • [2] Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
    Adams, Leon A.
    Anstee, Quentin M.
    Tilg, Herbert
    Targher, Giovanni
    [J]. GUT, 2017, 66 (06) : 1138 - 1153
  • [3] NAFLD and Infection, a Nuanced Relationship
    Adenote, Abimbola
    Dumic, Igor
    Madrid, Cristian
    Barusya, Christopher
    Nordstrom, Charles W.
    Rueda Prada, Libardo
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [4] Neutrophil function and metabolism in individuals with diabetes mellitus
    Alba-Loureiro, T. C.
    Munhoz, C. D.
    Martins, J. O.
    Cerchiaro, G. A.
    Scavone, C.
    Curi, R.
    Sannomiya, P.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (08) : 1037 - 1044
  • [5] Kupffer cells in non-alcoholic fatty liver disease: The emerging view
    Baffy, Gyoergy
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (01) : 212 - 223
  • [6] Innate immune cells in cirrhosis
    Bernsmeier, Christine
    van der Merwe, Schalk
    Perianin, Axel
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 186 - 201
  • [7] The Swedish cause of death register
    Brooke, Hannah Louise
    Talback, Mats
    Hornblad, Jesper
    Johansson, Lars Age
    Ludvigsson, Jonas Filip
    Druid, Henrik
    Feychting, Maria
    Ljung, Rickard
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (09) : 765 - 773
  • [8] NAFLD: A multisystem disease
    Byrne, Christopher D.
    Targher, Giovanni
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S47 - S64
  • [9] Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
    Dulai, Parambir S.
    Singh, Siddharth
    Patel, Janki
    Soni, Meera
    Prokop, Larry J.
    Younossi, Zobair
    Sebastiani, Giada
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Stal, Per
    Wong, Vincent Wai-Sun
    Kechagias, Stergios
    Hultcrantz, Rolf
    Loomba, Rohit
    [J]. HEPATOLOGY, 2017, 65 (05) : 1557 - 1565
  • [10] Feng D., 2020, Liver Res, V4, P23, DOI [10.1016/j.livres.2020.02.003, DOI 10.1016/J.LIVRES.2020.02.003]